ArticleCancer medicine2023

Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Zi-Jun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.